## **Core Concept**
The question tests the understanding of drug-induced hemolytic anemia, particularly in the context of pregnancy and antihypertensive medication. The key concept here involves identifying which antihypertensive drugs are known to cause hemolytic anemia.

## **Why the Correct Answer is Right**
The correct answer, , is likely correct because Methyldopa is a well-known antihypertensive drug that can cause hemolytic anemia, especially in pregnant women. This condition is a recognized side effect of Methyldopa, occurring due to the immune-mediated destruction of red blood cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because while it could potentially cause various side effects, it is less commonly associated with hemolytic anemia compared to Methyldopa.
- **Option B:** is incorrect as there is no commonly used antihypertensive drug by this name that is associated with hemolytic anemia.
- **Option C:** is incorrect because, although it can have several side effects, inducing hemolytic anemia is not commonly associated with it.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Methyldopa-induced hemolytic anemia can occur in pregnant women, and it is essential to monitor patients on Methyldopa for signs of hemolysis, such as decreased hemoglobin levels and increased reticulocyte count.

## **Correct Answer:** . Methyldopa